Table 4 The susceptibility of main Gram-Positive bacteria to common antibacterial drugs (%)
Antibiotics | Enterococcus faecalis | Enterococcus faecium | ||
|---|---|---|---|---|
Older | Younger | Older | Younger | |
Cefoperazone/Sulbactam | 9.1% | 14.3% | 0.0% | 10.0% |
Penicillin | 81.8% | 71.4% | 9.1% | 0.0% |
Tetracycline | 0.0% | 8.6% | 18.2% | 40.0% |
Gentamicin | 54.5% | 62.9% | 81.8% | 50.0% |
Tobramycin | 0.0% | 2.9% | 0.0% | 0.0% |
Vancomycin | 90.9% | 85.7% | 100.0% | 100.0% |
Ampicillin | 81.8% | 80.0% | 9.1% | 10.0% |
Piperacillin/Tazobactam | 9.1% | 11.4% | 0.0% | 0.0% |
Aztreonam | 0.0% | 5.7% | 0.0% | 0.0% |
Imipenem | 9.1% | 8.6% | 0.0% | 0.0% |
Meropenem | 9.1% | 0.0% | 0.0% | 0.0% |
Compound trimethoprim | 0.0% | 8.6% | 0.0% | 0.0% |
Nitrofurantoin | 63.6% | 80.0% | 9.1% | 30.0% |
Levofloxacin | 72.7% | 77.1% | 9.1% | 40.0% |
Amikacin | 9.1% | 11.4% | 0.0% | 0.0% |
Ciprofloxacin | 54.5% | 62.9% | 9.1% | 10.0% |